Multicenter, randomized, parallel-group, double-blind, placebo-controlled phase III stud of the efficacy and safety of quetiapine fumarate and lithium as monotherapy in 28 to 104 weeks maintenance treatment of bipolar I disorder in adult patient
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2006
At a glance
- Drugs Lithium; Quetiapine
- Indications Bipolar I disorders
- Focus Therapeutic Use
- 30 Mar 2006 New trial record.